Remsima infliximab new IV formulation contraindication

Reactions Weekly 2026

View at publisher

DOI: 10.1007/s40278-026-92731-3

Cited by: 0

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Rheumatoid Arthritis Research and Therapies Biosimilars and Bioanalytical Methods